In the transmembrane envelope glycoprotein (TM) of lentiviruses, including human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus (FIV), two cysteine residues, conserved in most retroviruses, are thought to form a loop containing five to seven amino acids. These elements make up a B-cell epitope recognized by nearly 100% of sera from infected patients or animals, designated the principal immunodominant domain (PID). The PID amino acid sequences are highly conserved between isolates of the same lentivirus but are unrelated, except for the two cysteines, when divergent lentiviruses are compared. The aim of this study was to analyze the relationship between amino acid sequence in the PID and envelope function. We introduced two kinds of mutations in the PID of FIV: mutations which impeded the formation of a loop and mutations which substituted the sequence of FIV with the corresponding sequences from other lentiviruses, HIV-1, visna virus, and equine infectious anemia virus. We analyzed antibody recognition, processing, and fusogenic properties of the modified envelopes, using two methods of Env expression: a cell-free expression system and transfection of a feline fibroblast cell line with gag-pol-deleted FIV proviruses. Most mutations in the PID of FIV severely affected envelope processing and abolished syncytium formation. Only the chimeric envelope containing the HIV-1 PID sequence was correctly processed and maintained the capacity to induce syncytium formation, although less efficiently than the wild-type envelope. We computed three-dimensional structural models of the PID, which were consistent with mutagenesis data and confirmed the similarity of FIV and HIV-1 PID structures, despite their divergence in amino acid sequence. Considering these results, we discussed the respective importance of selection exerted by functional requirements or host antibodies to explain the observed variations of the PIDs in lentiviruses.
The transmembrane glycoprotein (TM) of retroviruses is generated by proteolytic cleavage of a glycosylated envelope precursor (Pr) within the Golgi complex of infected cells. The TM is then transported to the cell surface and forms an oligomeric noncovalent complex with the surface glycoprotein (SU). Following the binding of SU to the cell surface receptor, the TM mediates fusion between the viral and the cellular membranes, allowing virus entry into the cell cytoplasm (for a review, see reference 17) . Despite the fact that little sequence homology is detected between envelope proteins of different retroviruses, the TM presents a common structural framework, organized in three domains: an extracellular ectodomain, a transmembrane anchor domain, and a C-terminal cytoplasmic domain (13) . Within the ectodomain, two vicinal cysteine residues, conserved in most retroviruses, define a potential loop structure (13, 25) . In the subfamily of lentiviruses, this potential loop structure is the main constituent of the principal immunodominant domain (PID), a B-cell epitope recognized by nearly 100% of infected patient or animal sera. This has been shown for human immunodeficiency virus type 1 (HIV-1) and HIV-2 and simian immunodeficiency virus (14, 24) , for equine infectious anemia virus (EIAV) (7) , for feline immunodeficiency virus (FIV) (12, 28) , and for caprine arthritisencephalitis virus (CAEV) (3) . In contrast to what is observed for the V3 loop of HIV-1, where immunodominance is associated with sequence variability, the amino acid sequence of the PID loop is highly conserved in the same lentiviral species, even in divergent isolates, such as HIV-1 LAI (previously HIV-1 BRU ) and HIV-1 MAL (1) (Fig. 1A) . Conversely, when different lentivirus species, for example HIV-1 and FIV, are compared, despite the conserved presence of the two cysteines, the amino acids within and outside the sequence delimited by the two cysteines are unrelated (Fig. 1A) .
Thus, the conservation of a potential loop structure between the two cysteines suggests the existence of an essential function of this domain in the retrovirus life cycle. Indeed, the substitution of both cysteines in HIV-1 TM has been shown to impair the Env Pr cleavage and to result in loss of viral infectivity (8, 38) . In a type D simian retrovirus (Mason-Pfizer monkey virus), a large (102-bp) deletion containing the cysteine domain of the TM also severely affected the processing of the Env Pr (4) . It has been proposed that the conserved TM loop may be involved in the association between SU and TM by noncovalent binding with the C-terminal portion of SU (16, 35) .
The aim of this work was to analyze the relationships between structure of the PID loop and envelope function in FIV. We introduced mutations in the FIV PID which impeded the formation of a loop structure or substituted the sequence of FIV between the two cysteines with the corresponding sequences from other lentiviruses: HIV-1, visna virus (VV), and EIAV. We observed that modification of the FIV PID structure impaired Env processing, producing nonfunctional envelopes. However, replacement of the FIV PID sequence with that of HIV-1 allowed the FIV envelope to maintain the ability to mediate cell-cell fusion. We computed three-dimensional structural models of the PID potential loop, which were consistent with mutagenesis data and confirmed the similarity of the structure of the mutant containing the HIV-1 sequence to that of FIV PID, despite their divergence in amino acid sequences.
MATERIALS AND METHODS

Construction of mutants.
The infectious molecular clone pFIV34TF10 (39) was obtained from J. Elder through the AIDS Research and Reference Reagent Program, National Institute of Allergy and Infectious Diseases.
The SpeI-PstI fragment of p34TF10, containing the 3Ј-terminal 1,187 bp of proviral genome, was introduced into pBluescript II KSϩ and used as the target for oligonucleotide-directed mutagenesis. Mutagenesis was performed by using an adaptation (11) of the method described by Kunkel (18) . We introduced a SacI site (positions 8351 to 8356) into the oligonucleotides, without changing the coded amino acids, upstream of the specific mutations in the TM2 site (8360 to 8383). This allowed screening of the colonies by enzymatic digestion of plasmid DNA prepared after transformation of Escherichia coli XL-1 blue cells. Mutants were then sequenced for confirmation.
The mutagenic oligonucleotides were designed to obtain two sets of mutations (Fig. 1B) . The first set of mutants was designed to impede the formation of the putative loop structure by deletion of the entire sequence between the two conserved cysteines (M1, or C⌬C [cysteine-deletion-cysteine]), substitution of serine for both cysteines residues (M2, or S-S [serine-loop-serine]), the first cysteine only (M3, or S-C [serine-loop-cysteine]), or the second only (M4, or C-S) (Fig. 1B) . The second set of mutants was designed to test the functional equivalence of unrelated sequences corresponding to the immunodominant loops of lentiviruses other than FIV. The sequences between the cysteines of the PIDs of HIV-1, VV, and EIAV were introduced in place of the corresponding sequence of FIV (M5, M6, and M7, respectively; Fig. 1B ). The sequences of these three lentiviruses were selected because they showed differences not only in primary sequence but also in the number of residues (six for FIV, five for HIV-1, six for VV, and seven for EIAV) and the number of charges (zero for FIV, one for HIV-1, two for VV and three for EIAV) within the potential loop structure (Fig. 1B) .
To analyze mutant envelopes, we constructed the Env expression vectors described below to use in vitro and ex vivo in cellular expression systems; the 8287-8918 SpeI-BstBI fragments containing mutations M1 through M7 were then introduced into the expression vectors. First, to obtain in vitro transcription and translation of env, the env gene and the 3Ј-terminal part of 34TF10 provirus were subcloned in pBluescript II KSϩ downstream of the T7 polymerase promoter, giving the pE plasmid. Second, to produce an FIV Env expression vector for use in feline cells, a deletion of gag and pol genes was introduced in 34TF10 provirus by Tth 111-EcoRV digestion and religation after Klenow treatment (27) . One clone, pT⌬20, with a deletion from nucleotides 923 to 5410 extending into the vif gene, expressed high levels of Env upon transfection of CrFK cells. Finally, the mutations which were shown to maintain a functional Env in cell expression assays were introduced into the infectious molecular clone p34TF10 to analyze the expression and infectivity of the mutant viruses.
In vitro transcription and translation. In vitro transcription using T7 polymerase (Ambion) on the pE wild-type and mutant plasmids and translation of RNA in the presence of [ 35 S]methionine in a rabbit reticulocyte lysate system (Promega) with the addition of dog pancreatic microsomal membranes to allow glycosylation of proteins were performed as described previously (30) . Translation products were lysed in 200 l of radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 2 mM EDTA, 1 mM phenylmethylsulfonyl fluoride) and were immunoprecipitated with 2 l of either pooled sera from FIV-infected cats or monoclonal antibody (MAb) DE4 (kindly provided by S. Lombardi, University of Pisa, Pisa, Italy). This antibody is reactive with amino acids 689 to 725 comprising the TM2 domain (21a). The M5 mutant, containing the HIV-1 sequence, was also immunoprecipitated with sera (diluted 1:25) from three different HIV-1-infected patients. Immunoprecipitated complexes were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (19) on an 8% polyacrylamide gel.
Cell transfection and Env analysis. Feline fibroblast cell line CrFK-HO6T1/2 (corresponding to the CrFK/ID10/R clone [26] ) was a gift of R. Osborne, MRC Retrovirus Research Laboratory, University of Glasgow, and was cultured in Dulbecco's modified Eagle's medium supplemented with 10% calf serum. Plasmids were purified by using the Promega maxiprep system and phenol-chlorophorm extraction. Transfection was performed by the calcium phosphate precipitation method (34) . Transfection conditions were optimized and standardized by using plasmids expressing the reporter gene encoding ␤-galactosidase or luciferase, kindly provided by U. Hazan and M. Alizon (Institut Cochin de Génétique Moléculaire, Paris, France). For kinetics and fusion assays, about 270,000 cells per well were plated in a six-well plate the day before transfection and were transfected with 3 g of DNA per well. Under these conditions, cells were confluent the third day after transfection.
(i) Detection and quantitation of Env glycoproteins by GN-ELISA. To quantitate the FIV Env products in cell lysates and in supernatants, we developed a sandwich enzyme-linked immunosorbent assay (ELISA) which uses solid-phaseadsorbed Galanthus nivalis agglutinin (GN) to bind Env glycoproteins (22) .
Samples were prepared as follows. Culture supernatants were centrifuged for 30 min at 7,000 ϫ g, treated with Empigen BB (0.25%, final concentration; Calbiochem), and spun again for 30 min at 13,000 ϫ g. Cells were washed with cold phosphate-buffered saline (PBS), lysed with 0.5% Empigen in 50 mM Tris-HCl (pH 7.5)-150 mM NaCl, and then centrifuged for 10 min at 1,200 ϫ g and for 1 h at 13,000 ϫ g. Sample dilutions were made in PBS-fetal calf serum (FCS) to bring the final concentration to 0.25% Empigen and to 10% FCS. In the experiments shown here, cell lysates were diluted 1:2. Protein content of cell lysates was measured by the bicinchoninic acid micromethod (Pierce) as instructed by the manufacturer.
ELISA was performed as follows: GN (Sigma), 10 g/ml in PBS, was used for coating 96-microwell plates (Nunc F-16 Maxisorp) overnight at room temperature. After blocking of wells with 10% FCS in PBS, 100-l aliquots of samples were added to duplicate wells and incubated overnight at 4ЊC. Supernatants or lysates from mock-transfected cultures were used as a control. After four washes with PBS containing 0.1% Tween 20 (washing buffer), 100 l of polyclonal rabbit immunoglobulin (Ig) elicited against a SU C-terminal peptide (P100) or against a TM C-terminal peptide (P102) (2) was added, and the mixture was incubated for 2 h at room temperature (ammonium sulfate precipitate stocks of rabbit Ig were diluted 1:1,000 in dilution buffer containing PBS, 10% FCS, and 0.1% Tween 20). After four washes, 100 l of a peroxidase-labelled anti-rabbit Ig (KPL; 1:1,000 in dilution buffer) was added, and the mixture was incubated for 1 h at room temperature. Plates were washed five times, and the reaction was visualized with 2,2Ј-azino-bis(3-ethylbenz-thiazoline)-6-sulfonic acid (ABTS) (0.2 mg/ml) and read at 405 nm after 30 min. As a positive control, dilutions of a FIV Petaluma supernatant stock from infected FL-4 cells (gift of J. Yamamoto, University of Florida) were included in each assay.
(ii) Fusion assays. The day after transfection, CrFK-HO6T1/2 cells were washed with cold PBS, trypsinized, and split in 4 wells of a 24-well plate. S-label (ICN) per ml. After being washed with cold PBS, cells were chased for 0, 4, and 8 h in 4 ml of Dulbecco's modified Eagle's medium containing 5ϫ methionine and cysteine and supplemented with 10% calf serum.
Cells were then lysed in L-RIPA buffer (LR buffer; 50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM MgCl 2 , 5 mM KCl, 1% Triton X-100, 0.5% deoxycholate, 1 mM phenylmethylsulfonyl fluoride). Nuclei and cell fragments were eliminated by sequential centrifugations (10 min at 1,200 ϫ g and 1 h at 17,000 ϫ g); 4-and 8-h-chase supernatants were centrifuged at 1,200 ϫ g and then filtered on a 0.22-m-pore-size filter. Supernatants were then diluted volume/volume with LR buffer and centrifuged (30 min at 17,000 ϫ g). Then 10 7 trichloroacetic acidprecipitable cpm of cell lysate and 6 ml of diluted supernatants were incubated overnight with 200 l of Sepharose-bound lentil lectin (Pharmacia) suspension in LR buffer. After four washes, bound glycoproteins were eluted from beads with 400 l of 0.5 M methyl-␣-D-mannopyranoside (Sigma) in LR buffer for 2 h. Eluates were adsorbed for 1 h with 75 l of a volume/volume suspension of Sepharose-protein A (Pharmacia) in LR buffer. After centrifugation, supernatants were incubated overnight with either pooled FIV-infected cat sera or polyclonal rabbit Ig against a synthetic peptide (P102) corresponding to a Cterminal sequence of FIV 34TF10 Env (amino acids 824 to 848) (2) (1:100, final dilution); 75 l of protein A was added, and the mixture was incubated for 1.5 h. After five washes, immunoprecipitates were eluted by boiling protein A beads in 50 l of Laemmli buffer. All steps before Laemmli elution were performed at 4ЊC. Immunoprecipitates were analyzed by SDS-PAGE on a 10 or 7 to 15% polyacrylamide gel.
Infectivity assays. CrFK-HO6T1/2 cells were transfected in six-well plates with the wild-type infectious molecular clone p34TF10 or the M5 (HIV) mutant provirus. After 48 h, cells were transferred to 25-cm flasks and cultured for 1 month. Reverse transcriptase (RT) activity of culture supernatants was monitored every 3 days by using a microtest (15) . For infectivity assays with cell-free virus, culture media were collected 32 h p.t., centrifuged, and filtered through 0.22-m-pore-size filters. One milliliter of filtered supernatant was added, in duplicate, to 48-well culture plates seeded the day before with 50,000 CrFK-HO6T1/2 cells per well. Cells were incubated for 1 h at 37ЊC, washed with PBS, and then given fresh medium. At 16 h or 3 days, cells were extensively washed, fixed, and immunostained with DF10, an anti-p24 MAb (21) (gift of S. Lombardi, University of Pisa), using the method described above.
Pulse-chase and RIPA analyses of cell lysates were performed following transfection of proviruses (15 g of DNA per 10-cm-diameter petri dish), using the conditions described above except that the lectin adsorption step was omitted. To analyze virion-associated proteins, cell cultures were labelled overnight beginning 32 h p.t. with 100 Ci of Trans- 35 S-label (ICN) per ml. Culture media were then collected and centrifuged at 1,200 ϫ g for 10 min. Supernatants were filtered through 0.22-m-pore-size filters, and virions were pelleted by centrifugation for 3 h through a 25% sucrose cushion at 25,000 rpm (Beckmann SW41 rotor). Pellets were dissolved in 200 l of RIPA buffer. Viral proteins were analyzed by RIPA as described above. In some experiments, virion-associated Env glycoproteins were also analyzed by L-RIPA.
Molecular modelling. The structures of the FIV TM2 peptide and of the corresponding peptides of mutants M5 (HIV-1), M6 (VV), and M7 (EIAV) (Fig.  1) were first built by using a molecular modelling package from Byosim Inc., using the Insight II Biopolymer module. Second, the structures were modelled by using the Amber force field and refined by energy minimization by using steepest and conjugate gradient with the Insight II Discover module. Third, exploration of the possible spatial conformations of each compound was performed by using high-temperature molecular dynamics simulation (5). An energy-dependent simulation of molecular motion was performed for each mutant over a 160-ps interval between 900 and 200 K, starting from the structures obtained with the Discover module. Every 10 ps, the conformation was recorded and the temperature was decreased by 50 K. Each recorded conformation was then energetically optimized by using a conjugate gradient until the maximum derivative was less than 0.001 kJ Å Ϫ1 mol Ϫ1 . A dielectric constant of 3.5 was chosen for our calculations to limit electrostatic interactions between the NH3ϩ and COOϪ groups. Fourth, all conformers were compared by using the Analysis module of Insight II. Conformational similarities were evaluated according to energy value and by calculating the root mean square deviation between the positions of backbone atoms. The low-energy structures were selected to represent the structure of each peptide. Considering that the modelled peptides are part of a larger molecule and that the N and C termini of all of the mutants are identical, a conformational constraint was applied by using the template structure of the FIV TM2 peptide for residues 1 to 3 and 13 to 15. Representative conformations of each mutants were compared with those of other mutants and with that of FIV TM2, using superimposition of C␣ atoms. 
RESULTS
Glycosylation and immunogenicity of mutant envelopes expressed in vitro. In vitro translation of the RNA produced from pE and the derived mutant vectors, in which the env gene is under the control of the T7 RNA polymerase promoter, allowed comparison of the wild-type and mutated Env proteins. Figure 2 shows an analysis by RIPA of env translational products. Mutated Env proteins (M2, M6, and M7 [ Fig. 2A] and M5 [ Fig. 2B] ) presented electrophoretic mobilities identical to that of the wild-type Env protein (W). The nonglycosylated Env precursor protein showed an apparent size of 90 kDa. Following glycosylation in the presence of dog microsomal membranes, two major glycosylated products with apparent sizes of 150 and 130 kDa were obtained. The mutant Env proteins could be precipitated by sera from FIV-infected cats (C in Fig. 2A) , like the wild-type Env, but not by MAb DE4 directed to the FIV immunodominant region (Fig. 2A, M2 , M6, and M7). This result confirmed that the mutated envelope proteins conserved most of their immunological reactivity and that, as expected, the introduced mutations affected the recognition of the PID. In addition to the sera from infected cats, the mutant envelope M5, containing the HIV-1 sequence, could also be precipitated by sera from three HIV-1-infected individuals (H in Fig. 2B ), indicating that the amino acid sequence located between the cysteines of the PID is sufficient for the reaction with natural anti-HIV-1 antibodies.
Influence of PID mutations on envelope processing and SU release ex vivo. To analyze the cell expression and processing of the mutated envelope proteins, we cloned the mutated env genes into the pT⌬20 expression vector. After transfection of CrFK cells, Env glycoprotein expression was analyzed by pulselabelling and L-RIPA, using either a pool of sera from FIVinfected cats (Fig. 3A) or rabbit polyclonal antibodies directed to a C-terminal peptide of FIV TM (Fig. 3B) . Following the pulse-labelling, both antibodies precipitated a protein with an apparent size of 130 kDa, corresponding to the Env Pr (37, 41) , from the lysates of cells transfected with both the mutant and the wild-type Env (Fig. 3A and B, time 0) . A slight decrease of the Pr molecular weight was observed after a 4-h chase (Fig.  3A and B, time 4) , probably caused by trimming of glycan side chains in the endoplasmic reticulum (37) . The wild-type Pr (W in Fig. 3 ) was subsequently cleaved into the mature SU (gp100) and TM (gp36) glycoproteins, which were precipitated by the infected cat sera after 4-and 8-h chase periods (Fig. 3A) . The TM glycoprotein appeared as a diffuse band (39) , which was barely visible in the RIPA performed with anti-TM antibodies. Uncleaved Pr also persisted after an 8-h chase (Fig. 3A and B) , indicating that the Pr is not completely processed, as has been previously observed in FIV-infected cells (37) . For the mutants, in spite of the reduction in intensity of the Pr band during the chase, the cell-associated SU and TM subunits were not detected on the autoradiograms (Fig. 3A, M1 to M7) . However, when cell culture supernatants were analyzed, the presence of a band migrating at the same size as the wild-type SU was observed for all mutants following 4-and 8-h chases (Fig. 3C) , although the intensity of the bands of the mutants
FIG. 3. Pulse-chase analysis of Env glycoproteins expressed upon transfection of CrFK cells with Env expression vectors containing the 34TF10 env gene (W) or the mutated env (M1 to M7). Mo, mock transfection. L-RIPA was performed as described in Materials and Methods. Cell lysates were immunoprecipitated with either a pool of sera from FIV-infected cats (A) or rabbit Ig against a C-terminal peptide of the TM (B). Supernatants were precipitated with a pool of infected cat sera (C).
In panels A and B, numbers above lanes represent hours of chase before harvesting of cell lysates. In panel C, time of chase before harvesting of cell-free culture media is indicated on the left. Precipitated Env glycoproteins are indicated by arrows on the right; on the left are indicated molecular weight standards. (A and C) SDS-PAGE (10% gel); (B) SDS-PAGE (7 to 15% gel). We used a quantitative ELISA to evaluate the SU production and release in the culture supernatants. To differentiate the ELISA reaction due to SU from that due to Pr and TM, we used antibodies directed to the C terminus of SU, which detect both SU and Pr, or to the C terminus of TM, which react with both TM and Pr. We transfected CrFK cells with the different plasmid constructs and measured the cell-associated and secreted Env products in the cell lysates and in the culture supernatants, respectively, 50 h p.t. Cell lysates for the wild type and all of the mutants displayed similar reactivities with both the anti-SU and the anti-TM antibodies, as expected from the prominent amount of the Pr evidenced by RIPA (not shown). Conversely, the reactivity of the supernatants with the anti-TM antibodies remained at the background level (optical density below 0.15), while a clear positive reaction was detected with the anti-SU antibodies (optical density ranging from 0.814 for mutant M3 [S-C] to 2.099 for the wild-type pT⌬20, the mean of the mock transfection supernatants being 0.223). Thus, no detectable Pr or TM was found in the supernatants. The reactivity of the supernatants with the anti-SU antibodies could, therefore, be taken as a measure of the released SU protein.
Env production was then measured at 6, 28, 50, and 72 h p.t. by using the anti-SU antibodies. The kinetics of cell-associated Env production from the wild-type and mutant env genes were similar (Fig. 4A) . In contrast, the amount and the kinetics of SU release in the supernatant showed a marked contrast between the wild type and most of the mutants (Fig. 4B) . The amount of secreted SU from the wild type was low at 6 h p.t. and then increased rapidly until the appearance of a cytopathic effect after 48 h. At 6 h p.t., the amount of secreted SU from the mutants was comparable to or higher than that of the wild type but then showed little if any increase. The M5 mutant, containing the HIV-1 PID sequence, presented an intermediate pattern: the SU level in supernatant was low at 6 h p.t. and then gradually increased until 72 h. These experiments were performed five times, giving reproducible results, and Fig. 4B shows a representative set of experiments.
Effects of PID loop exchange on envelope fusogenic properties. We evaluated the ability of the wild-type and mutant Env glycoproteins to mediate cell membrane fusion by transfection of the Env expression vectors in CrFK cells and detection of syncytium formation. Fusion assays were repeated for each vector four times and gave reproducible results. Figure 5 shows one set of assays. Following transfection with the wild-type Env expression vector, multinucleated cells were seen the day after transfection. At 48 h, giant syncytia, containing several dozens of nuclei, covered the well surface (Fig. 5) . In contrast, transfection of the Env mutants, with the exception of M5 (HIV), failed to induce syncytium formation. Single transfected cells, expressing Env glycoproteins, were stained by the anti-SU MAb VPG 68 (Fig. 5) . Only the HIV/FIV chimera, M5, was able to induce syncytium formation (Fig. 5) , although the syncytia were smaller (5 to 20 nuclei at 48 h p.t.) than those induced by the wild type. The size and number of syncytia induced by M5 (HIV) Env further increased with the time up to 72 h (not shown).
Gene expression and infectivity of a mutated FIV molecular clone. The chimeric FIV env gene containing the sequence of the HIV-1 PID, which was shown to produce fusogenic envelope, was introduced into an FIV infectious molecular clone (p34TF10). After transfection of CrFK cells with the mutant molecular clone, RT activity was detected in the supernatant but was progressively lost after 9 days (corresponding to two cell passages) (Fig. 6A) . Accordingly, incubation of fresh CrFK cells with cell-free virus produced by transfection with the wild-type clone p34TF10 resulted in the detection of foci of infection, whereas the corresponding experiment using the mutant genome did not (not shown). However, direct transfection of CrFK cells with the mutant proviral clone did result in induction of syncytia, similar to levels previously observed for the M5 (HIV) Env expression vector. Syncytia appeared after 2 days p.t. and persisted until day 6. To determine whether an impairment in gene expression or virus production could be responsible for the observed inability of the mutant molecular clone to generate infectious virus, we analyzed cell-associated and virion-associated proteins by RIPA after transfection of CrFK cells with the wild-type and M5 (HIV) molecular clones (Fig. 6B ). Viral structural proteins were detected in cell lysates and in pelleted virions for both mutant and wild-type viruses, indicating that complete viral particles were assembled and released in the supernatant, although less SU gp100 was observed in the mutant viral pellet than in the wild-type viral pellet (Fig. 6B) .
Computer models. The structural models obtained for the FIV TM2 domain and the three mutants M5 (HIV), M6 (VV), and M7 (EIAV) are shown in Fig. 7 . The amino acids between the cysteines formed a compact globular structure in all cases, in agreement with previous data of computer modelling or proton nuclear magnetic resonance studies on the PID of HIV-1 (25, 35) . When the three mutant models were superimposed upon the FIV TM2 model according to the alignment shown in Fig. 1B , root mean square deviations for C␣ atoms (relative to TM2) were 2.49, 2.84, and 2.64, for M5 (HIV), M6 (VV), and M7 (EIAV), respectively. These values indicated the similarity of the backbone structures, the main differences being due to amino acid side chains. The volumes of the different structures were 1,059, 1,233, 1,334, and 1,337 Å 3 (1Å ϭ 0.1 nm) for M5 (HIV), FIV TM2, M6 (VV), and M7 (EIAV), respectively. The total areas were 590, 696, 805, and 808 Å 2 for M5 (HIV), FIV TM2, M6 (VV), and M7 (EIAV), respectively. These loop size differences may explain the functional differences observed between mutant envelopes. The comparison between M7 (EIAV) and FIV TM2 by superimposition of C␣ atoms showed differences in steric bulk for Phe at position 11, Arg at position 7, Thr at position 8 in M7 (EIAV), and Gln at position 6 in FIV TM2. The main differences between M6 (VV) and FIV TM2 were in Tyr-7, Gln-9, and His-6 of M6 (VV) and Phe-11 and Gln-6 of FIV TM2. M5 (HIV) and FIV TM2 models displayed a good match in terms of volume. M5 could be almost completely contained within TM2: only a difference due to the protrusion of Gln-6 of TM2 was observed. These modelling results are thus consistent with the conserved fusogenic activity of mutant M5 (HIV).
DISCUSSION
In the ectodomain of the FIV TM glycoprotein, a pentapeptide comprised between two cysteines represents an immunodominant linear B-cell epitope (TM2) (2a). The two cysteine residues, probably linked by a disulfide bridge to form a loop, are present in the TM of most retroviruses. Moreover, despite important variations of amino acid sequences within the potential loop, the immunodominance of this domain is also highly conserved in several primate and nonprimate lentiviruses (reviewed in reference 29). In this work, we tested the influence of the PID structure on the synthesis and processing of FIV Env and on the fusogenic properties of FIV TM. We introduced mutations in FIV TM which affected the possibility (8, 38) . The amount of Env Pr detected during the chase decreased for the mutant Env proteins, without the appearance of intracellular cleavage products. This result suggests that the unprocessed fraction of the Pr might undergo intracellular degradation. However, some degree of Pr processing does occur, as evidenced by detection via L-RIPA and ELISA of mature SU protein in the supernatants of cells transfected with the mutant Env expression vectors ( Fig. 3C and 4B ). It is not clear whether the failure to detect intracellular TM was due only to experimental difficulty in visualizing low amounts of FIV TM as also reported by others (41) or, in addition, to a rapid degradation of the TM after SU dissociation. In previously reported experiments involving mutagenesis of the PID cysteines of HIV-1, no SU was detected in supernatants (8, 38) . This discrepancy may result from differences between HIV-1 and FIV, from variable efficiency of Pr cleavage in different cell systems (9) , or from differences in the sensitivity of assays employed for SU detection. It might also be suggested that part of the glycoprotein detected in supernatants by the anti-SU antibodies does not derive from the SU/TM cleavage of the Pr but from alternative Env expression, as observed for HIV-1 in vitro (11) and in cells (42) . However, in HIV-1 Env processing, alternatively processed Env protein was detected only during the first 5 to 30 min of pulse-labelling and was of higher molecular weight than the SU (42) . On the contrary, the FIV Env glycoprotein that we detected by L-RIPA in supernatants was present during 8 h of chase and had the same molecular weight as the wild-type SU.
We observed that the kinetics of SU accumulation in supernatants differed between wild-type Env and most of the mutants. Indeed, while in the wild-type a low level of released SU was observed at 6 h p.t., followed by a rapid increase, some mutants showed a rapid initial release of SU, without noticeable accumulation with time. This finding might suggest that mutations resulted in rapid initial dissociation of SU from TM and diminished long-term accumulation due to impeded Pr processing. This interpretation agrees with the model proposed by Schulz et al. (35) , in which the PID loop is involved in SU-TM association. Accordingly, the kinetics of SU secretion by mutant M5 (HIV), which contains the HIV-1 PID sequence and remained fusogenic, resembled the wild-type kinetics: low secretion of SU during the first hours of monitoring followed by consistent long-term accumulation of SU. Our computer models suggest that, introduced in the context of the FIV envelope, the HIV-1 sequence has a threedimensional structure closer to that of FIV TM2 than of VV and EIAV sequences, supporting the hypothesis that the spatial configuration, more than the primary sequence, accounts for the function of the immunodominant domain. In addition to structural modifications, changes of charge could also affect the relation of the TM loop to other regions involved in the formation of the mature Env complex (16) . Indeed, the FIV sequence does not contain charged amino acids, whereas those of VV and EIAV contain two and three charged amino acids, respectively. In a feline oncovirus, feline leukemia virus, one replication-defective molecular clone, 61B, presented two changes from negatively to positively charged amino acids between the conserved cysteines (40) . According to the model of Schulz et al. (35) , the PID interacts with a pocket formed by the C-terminal extremity of SU. Interestingly, we observed amino acid sequence homology between HIV-1 and FIV in the proposed pocket region at the C terminus of SU:
(consensus sequences from references 23 and 30). Such homology, not seen with other lentiviruses, could explain the partial conservation of fusogenic properties of the FIV-HIV-1 chimeric TM, by allowing its association with the FIV SU. Additional mutagenesis in the SU C terminus could allow testing this hypothesis.
The M5 (HIV) mutation did not abolish Env fusogenic ability upon transfection of CrFK cells but abrogated the capacity of the infectious molecular clone p34TF10 to give rise to a productive infection. In the case of HIV-1, it was proposed that virion infectivity is compromised below a critical surface density of SU (20) . Similarly, it is tenable that the M5 (HIV) mutation gave rise to noninfectious virions because of a low surface density of SU resulting from a reduction in Env Pr maturation. Such hypothesis is supported by the lower amount of gp100 detected in M5 (HIV) mutant virions relative to that in wild-type virions (Fig. 6B) . The overexpression of Env in the first days after transfection probably compensated these defects and produced sufficient cleaved products at the cell surface to induce fusion.
Nevertheless, the conservation of some fusogenic ability by the HIV-1/FIV chimeric envelope indicates the tolerance of the TM to sequence replacement within the PID. In this context, it is not clear whether the requirements for Env processing and function are sufficient to explain the high conservation of the PID sequence between different isolates of a given lentivirus. In HIV-1, antibodies against the PID are not neutralizing (6) . On the contrary, human MAbs directed against this epitope enhanced virus infection of a T-cell line (31) . In addition, in the case of CAEV, an association has been observed between the serological reactivity to the immunodominant TM epitope and the presence of arthritis in CAEVinfected goats (3) . If the host antibody response against the PID of lentiviruses enhances viral entry of host cells (for example, macrophages) and the dissemination of virus in vivo, this would create a strong selection pressure to maintain the immunodominance of this structure in infected individuals and species. This selection would depend not only on TM function but also on the host repertoire or the specificity of antibodies induced during initial seroconversion. Our results thus open interesting issues: additional mutagenesis could be performed in the PID in order to modify its immune recognition without impairing Env processing and virus entry. This would allow dissection of the respective roles of the two conserved properties of the PID, physical structure and B-cell immunodominance, and would also address the importance of antibody response for lentivirus pathogenesis. 
